Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
28 January 2016
Header
Header image
From our blog

From our blog

From Russia with Love
28 January 2016 by Richard Bergström

Well, maybe “love” is too strong a word, but I could not resist using the title of an old Bond movie starring Sean Connery.

There is something captivating about Russia. Not only is Moscow stunning in winter; it is also “grand” and “proud” and full of clever people.

Read more

From our blog

Naturally Sceptical, the Media Will Doubtless Scrutinise Pharma’s New Transparency Initiative
28 January 2016 by Sten Stovall

It seems Pharma’s standing among general practitioners (GPs) could use some serious improving – and that doing so would be in the industry’s own interests. Also, as cutting-edge drug innovations occur at a rising rate, family doctors will need as much insight as possible into what they can prescribe to end-users, the patients, and why. So that gulf between GPs and Pharma needs to be narrowed, not least for the sake of the patient.

Read more

From our blog

Statement on the recent serious adverse events that happened in a clinical trial in France
28 January 2016 by Stefano Marini, Dagmar Chase (EUCROF)

The recent events that occurred in a clinical trial conducted in France, in which one clinical trial subject lost his life and several other trial participants became seriously ill, are tragic. Members of EUCROF, the European Federation of Contract Research Organisations, view these issues with serious concern and regret.

Read more

Events calendar

Events Calendar

EFPIA Annual Conference 2016
On 15/06/2016 (Radisson Hotel, Brussels)

This year's EFPIA Annual Conference will take place on 15 June 2016, at the Radisson Hotel in Brussels. The event will examine the challenges faced by healthcare systems in Europe, the exciting science that will play a key role in meeting these challenges and the long-term sustainability of healthcare delivery. An interactive exhibition will be set up to provide attendees with further insight into EFPIA’s current initiatives, which aim at facilitating a pan-European dialogue on the importance of shifting towards a model of outcomes-driven healthcare.
 
The final programme can be accessed here
 
Read more

Events Calendar

2016 China/EU Pharmaceutical Industry Forum
On 05/04/2016 (Hamburg, Germany)

CPIA and EFPIA will organise a workshop on 5 April 2016, in Hamburg, Germany, with the following areas of focus: an overview of the pharmaceutical market in China/EU; Pharmaceuticals in the Environment; the Drug Administration Law (DAL) revision; and the implementation of new EU legislation. 

The workshop takes place the day before the start of the DIA Euro meeting, which will facilitate for those who already plan to attend the DIA Euro meeting in Hamburg.
 
This will be an excellent opportunity to listen to e.g. a presentation on the revision of the Drug Administration Law in China and the European Commission strategy for Pharmaceuticals in the Environment (PIE) and also get direct information from the Commission on what will happen in 2019 re Identification and authentication of medicines in Europe as a result of the implementation of the Falsified Medicines Directive.
 
Please see the programmme for further details. Below, you can access the speakers' presentations:
 
European Commission strategy for Pharmaceuticals in the Environment (PIE), Patrizia Tosetti, Medical products: quality, safety, innovation, European Commission
 
 
Read more

Events Calendar

Inaugural Conference of the European Institute for Innovation through Health Data (i~HD)
On 10/03/2016 (Paris, France)

This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The role of i~HD, as a not-for-profit Institute, is to provide independent governance oversight of such services now, and as these expand to connect with many more hospitals across Europe. The conference will present this platform and its pharma-led adoption programme, and detail the i~HD governance services that reflect state-of-the-art in the trustworthy re-use of health data for research. You will also learn about Europe's largest "big data" project in health: EMIF (European Medical Information Framework). The views of patients on the benefits of reusing their data for research will be presented by Mary Baker, past President of the European Brain Council, one of our keynote speakers.

For more information, please click here

Read more

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

Documents

From our blog

Vaccines: A tool for spending smart
28 January 2016 (Publications)

Vaccination programmes have had a significant impact on reducing mortality and morbidity throughout life from numerous infectious diseases, saving 2 to 3 million lives worldwide [...] Read more

What we are reading

What we are reading

Pharmaceuticals and universities provide £40m fund for translational research
28 January 2016 (Imperial College London)

The Apollo Therapeutics Fund offers Imperial academics and partners a new opportunity to drive forward therapeutic innovation.

Read more

What we are reading

Funding programme analysis reveals ‘substantial’ impact on EU competitiveness
28 January 2016 (European Commission)

The EU’s 2007-2013 research funding programme has had a ‘substantial’ impact on competitiveness in Europe, according to a European Commission report and the findings of an independent panel. 

Read more

What we are reading

An open relationship
28 January 2016 (PharmaTimes)

Moves to boost transparency in the relationships between healthcare professionals and pharmaceutical companies come into fruition this year, but what challenges and opportunities will disclosure create? (Page 31)

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail